Wetenschap

International Consensus on ANA Patterns (ICAP): inbedding in het Nederlandse taalgebied

Lees online

In het kader van harmonisatie van de rapportage van auto-immuundiagnostiek is er sinds enkele jaren internationale consensus over de nomenclatuur en definitie van HEp-2-patronen die met behulp van indirecte immuunfluorescentie (IIF) te onderscheiden zijn. Deze test wordt gebruikt om anticellulaire antistoffen aan te tonen die veelal gerapporteerd worden als antinucleaire antistoffen (ANA) en een belangrijke rol spelen in de diagnostiek van systemische auto-immuunziekten. In een nauwe samenwerking tussen het Belgische en Nederlandse EASI-team is de consensus beschikbaar gemaakt voor het Nederlandse taalgebied. Uitgangspunt is dat de Nederlandstalige benamingen van de verschillende HEp-2-patronen breed ingevoerd gaan worden in klinische laboratoria in Nederland en Vlaanderen.

Literatuur

  1. Mahler M, Meroni PL, Bossuyt X, Fritzler MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014;2014:315179.
  2. Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47:434-44.
  3. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420-2.
  4. Damoiseaux J, Bakker-Jonges L, Cohen Tervaert JW, et al. Laboratory diagnosis of ANA, anti-ds-DNA- and anti- ENA-antibodies: recommendation following the outcomes of a questionnaire. Ned Tijdschr Klin Chem Labgeneesk 2010;35:234-9.
  5. Damoiseaux J, Agmon-Levin N, Van Blerk M, et al. From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries. Clin Exp Rheumatol 2014;32:539-46.
  6. Van Blerck M, Bossuyt X, Humbel R, et al. Belgian recommendations on ANA, anti-dsDNA and anti-ENA antibody testing. Acta Clin Belg 2014;69:83-6.
  7. Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73:17-23.
  8. Op De Beeck K, Vermeersch P, Verschueren P, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011;10:801-8.
  9. Oyaert M, Bossuyt X, Ravelingien, Van Hoovels L. Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting. Clin Chem Lab Med 2016;54:63-6.
  10. Van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis. an American College of Rheumatology/European League against Rheumatism collaborative initiative. Ann Rheum Dis 2013;65:2737-47.
  11. Chan EK, Damoiseaux J, Carballo OG, et al. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014–2015. Front Immunol 2015;6:412.
  12. Chan EKL, Fritzler MJ, Wiik A, et al. ; IUIS/WHO/AF/CDC Committee for the Standardization of Autoantibodies in Rheumatic and Related Diseases. Autoantibody standardization committee in 2006. Autoimmun Rev 2007;6:577-80.
  13. Dellavance A, Junior AG, Cintra AFU, et al. The first Brazilian consensus for standardization of ANA in HEp-2 cells. Jornal Brasileiro de Patologiae Medicina Laboratorial 2001;38:207-16.
  14. Wiik AS, Hoier-Madsen M, Forslid J, et al. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 2010;35:276-90.
  15. Chan EK, Damoiseaux J, de Melo Cruvinel W, et al. Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015. Lupus 2016;25:797-804.
  16. Damoiseaux J, von Mühlen CA, Garcia-de la Torre I, et al. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. AutoImmun Highlights 2016;7:1.
  17. Bentow C, Fritzler MJ, Mummert E, Mahler M. Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey. AutoImmun Highlights 2016;7:8.
  18. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification ofsystemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
  19. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic LupusInternational Collaborating Clinics classification criteria for systemiclupus erythematosus. Arthritis Rheum 2012;64:2677-86.
  20. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune HepatitisGroup Report: review of criteria for diagnosis of autoimmunehepatitis. J Hepatol 1999;31:929-38.
  21. Vergani D, Alvarez F, Bianchi FB, et al; International Autoimmune Hepatitis Group. Liver autoimmune serology: a consensusstatement from the committee for autoimmune serology of theInternational Autoimmune Hepatitis Group. J Hepatol 2004;41:677-83.
Wetenschap

International Consensus on ANA Patterns (ICAP): inbedding in het Nederlandse taalgebied

In het kader van harmonisatie van de rapportage van auto-immuundiagnostiek is er sinds enkele jaren internationale consensus over de nomenclatuur en definitie van HEp-2-patronen die met behulp van indirecte immuunfluorescentie (IIF) te onderscheiden zijn. Deze test wordt gebruikt om anticellulaire antistoffen aan te tonen die veelal gerapporteerd worden als antinucleaire antistoffen (ANA) en een belangrijke rol spelen in de diagnostiek van systemische auto-immuunziekten. In een nauwe samenwerking tussen het Belgische en Nederlandse EASI-team is de consensus beschikbaar gemaakt voor het Nederlandse taalgebied. Uitgangspunt is dat de Nederlandstalige benamingen van de verschillende HEp-2-patronen breed ingevoerd gaan worden in klinische laboratoria in Nederland en Vlaanderen.

Literatuur

  1. Mahler M, Meroni PL, Bossuyt X, Fritzler MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014;2014:315179.
  2. Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47:434-44.
  3. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420-2.
  4. Damoiseaux J, Bakker-Jonges L, Cohen Tervaert JW, et al. Laboratory diagnosis of ANA, anti-ds-DNA- and anti- ENA-antibodies: recommendation following the outcomes of a questionnaire. Ned Tijdschr Klin Chem Labgeneesk 2010;35:234-9.
  5. Damoiseaux J, Agmon-Levin N, Van Blerk M, et al. From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries. Clin Exp Rheumatol 2014;32:539-46.
  6. Van Blerck M, Bossuyt X, Humbel R, et al. Belgian recommendations on ANA, anti-dsDNA and anti-ENA antibody testing. Acta Clin Belg 2014;69:83-6.
  7. Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73:17-23.
  8. Op De Beeck K, Vermeersch P, Verschueren P, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011;10:801-8.
  9. Oyaert M, Bossuyt X, Ravelingien, Van Hoovels L. Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting. Clin Chem Lab Med 2016;54:63-6.
  10. Van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis. an American College of Rheumatology/European League against Rheumatism collaborative initiative. Ann Rheum Dis 2013;65:2737-47.
  11. Chan EK, Damoiseaux J, Carballo OG, et al. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014–2015. Front Immunol 2015;6:412.
  12. Chan EKL, Fritzler MJ, Wiik A, et al. ; IUIS/WHO/AF/CDC Committee for the Standardization of Autoantibodies in Rheumatic and Related Diseases. Autoantibody standardization committee in 2006. Autoimmun Rev 2007;6:577-80.
  13. Dellavance A, Junior AG, Cintra AFU, et al. The first Brazilian consensus for standardization of ANA in HEp-2 cells. Jornal Brasileiro de Patologiae Medicina Laboratorial 2001;38:207-16.
  14. Wiik AS, Hoier-Madsen M, Forslid J, et al. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 2010;35:276-90.
  15. Chan EK, Damoiseaux J, de Melo Cruvinel W, et al. Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015. Lupus 2016;25:797-804.
  16. Damoiseaux J, von Mühlen CA, Garcia-de la Torre I, et al. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. AutoImmun Highlights 2016;7:1.
  17. Bentow C, Fritzler MJ, Mummert E, Mahler M. Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey. AutoImmun Highlights 2016;7:8.
  18. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification ofsystemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
  19. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic LupusInternational Collaborating Clinics classification criteria for systemiclupus erythematosus. Arthritis Rheum 2012;64:2677-86.
  20. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune HepatitisGroup Report: review of criteria for diagnosis of autoimmunehepatitis. J Hepatol 1999;31:929-38.
  21. Vergani D, Alvarez F, Bianchi FB, et al; International Autoimmune Hepatitis Group. Liver autoimmune serology: a consensusstatement from the committee for autoimmune serology of theInternational Autoimmune Hepatitis Group. J Hepatol 2004;41:677-83.
Over dit artikel
Auteurs
Jan Damoiseaux, Xavier Bossuyt, Sylvia Broeders, Dörte Hamann, Karina de Leeuw, Maarten Limper, Henny Otten, Caroline Roozendaal, Sofie Schouwers, Marco Schreurs, Rogier Thurlings, Paul van Daele, Renate van der Molen, Lieve van Hoovels, Martine Vercammen, Carolien Bonroy
Over de auteurs

Jan Damoiseaux, Centraal Diagnostisch Laboratorium, MUMC, Maastricht;
Xavier Bossuyt, Afdeling Laboratoriumgeneeskunde, Universitaire Ziekenhuizen Leuven, Leuven;
Sylvia Broeders, Sciensano, Brussel;
Dörte Hamann, Sanquin Diagnostiek BV, Amsterdam;
Karina de Leeuw, Afdeling Reumatologie en Klinische Immunologie, UMCG, Groningen;
Maarten Limper, Afdeling Reumatologie en Klinische Immunologie, UMCU, Utrecht;
Henny Otten, Laboratorium voor Translationele Immunologie, UMCU, Utrecht;
Caroline Roozendaal, Afdeling Laboratoriumgeneeskunde, UMCG, Groningen;
Sofie Schouwers, Afdeling Laboratoriumgeneeskunde, GZA Ziekenhuizen, Antwerpen;
Marco Schreurs, Laboratorium Medische Immunologie, Erasmus MC, Rotterdam;
Rogier Thurlings, Afdeling Reumatische Ziekten, Radboudumc, Nijmegen;
Paul van Daele, Afdeling Interne Geneeskunde, Erasmus MC, Rotterdam;
Renate van der Molen, Afdeling Laboratoriumgeneeskunde, Radboudumc, Nijmegen;
Lieve Van Hoovels, Klinisch Laboratorium, Onze-Lieve-Vrouwziekenhuis, Aalst;
Martine Vercammen, Afdeling Laboratoriumgeneeskunde, AZ Sint-Jan Ziekenhuis, Brugge;
Carolien Bonroy, Laboratorium voor Klinische Biologie, UZ Gent, Gent

Correspondentieadres: jan.damoiseaux@mumc.nl

E-pubdatum
2 juli 2018
ISSN online
2589-6296


Over dit artikel
Auteurs
Jan Damoiseaux, Xavier Bossuyt, Sylvia Broeders, Dörte Hamann, Karina de Leeuw, Maarten Limper, Henny Otten, Caroline Roozendaal, Sofie Schouwers, Marco Schreurs, Rogier Thurlings, Paul van Daele, Renate van der Molen, Lieve van Hoovels, Martine Vercammen, Carolien Bonroy
Over de auteurs

Jan Damoiseaux, Centraal Diagnostisch Laboratorium, MUMC, Maastricht;
Xavier Bossuyt, Afdeling Laboratoriumgeneeskunde, Universitaire Ziekenhuizen Leuven, Leuven;
Sylvia Broeders, Sciensano, Brussel;
Dörte Hamann, Sanquin Diagnostiek BV, Amsterdam;
Karina de Leeuw, Afdeling Reumatologie en Klinische Immunologie, UMCG, Groningen;
Maarten Limper, Afdeling Reumatologie en Klinische Immunologie, UMCU, Utrecht;
Henny Otten, Laboratorium voor Translationele Immunologie, UMCU, Utrecht;
Caroline Roozendaal, Afdeling Laboratoriumgeneeskunde, UMCG, Groningen;
Sofie Schouwers, Afdeling Laboratoriumgeneeskunde, GZA Ziekenhuizen, Antwerpen;
Marco Schreurs, Laboratorium Medische Immunologie, Erasmus MC, Rotterdam;
Rogier Thurlings, Afdeling Reumatische Ziekten, Radboudumc, Nijmegen;
Paul van Daele, Afdeling Interne Geneeskunde, Erasmus MC, Rotterdam;
Renate van der Molen, Afdeling Laboratoriumgeneeskunde, Radboudumc, Nijmegen;
Lieve Van Hoovels, Klinisch Laboratorium, Onze-Lieve-Vrouwziekenhuis, Aalst;
Martine Vercammen, Afdeling Laboratoriumgeneeskunde, AZ Sint-Jan Ziekenhuis, Brugge;
Carolien Bonroy, Laboratorium voor Klinische Biologie, UZ Gent, Gent

Correspondentieadres: jan.damoiseaux@mumc.nl

E-pubdatum
2 juli 2018
ISSN online
2589-6296